Summary

Report Summary

Cencora Inc Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Cencora Inc's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Cencora Inc including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Cencora Inc's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Cencora Inc's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Cencora Inc's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Cencora Inc's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Cencora Inc enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Cencora, Inc., formerly known as AmerisourceBergen Corporation until its rebranding in August 2023, is a leading global pharmaceutical sourcing and distribution company founded in 2001. Headquartered in Conshohocken, Pennsylvania, the company operates across multiple geographies, including the United States and Europe, serving a diverse range of healthcare providers and markets. The company’s U.S. Healthcare Solutions segment delivers pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and related services to hospitals, health systems, retail and mail-order pharmacies, medical clinics, and long-term care facilities. This segment also provides pharmacy management, staffing, consulting, supply management software, packaging solutions, clinical trial support, commercialization services, and data analytics for biotechnology and pharmaceutical manufacturers. Additionally, it serves animal health markets and offers sales force support, plasma and injectable product distribution, and specialty services to physicians, hospitals, and dialysis clinics. Cencora’s International Healthcare Solutions segment focuses on pharmaceutical wholesale, global commercialization, and healthcare product distribution primarily in Europe. It also provides specialty transportation and logistics services for the biopharmaceutical industry, reinforcing its global footprint and comprehensive healthcare supply chain expertise.

Cencora Inc in the News:-

2026-05-27 - Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
2026-05-06 - Cencora leaders share insights at Asembia ASX26
2026-04-24 - Supply chain experts discuss FDA 12-digit NDC format
2026-03-17 - Cencora announces financial leadership transition
2026-03-04 - Matt Sample on DSCSA Developments 2026


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Cencora Inc's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Cencora Inc's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Cencora Inc's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Cencora Inc's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Cencora Inc:

• Cencora Inc PESTLE Analysis
• Cencora Inc Value Chain Analysis
• Cencora Inc Porter's Five Forces Analysis
• Cencora Inc VRIO Analysis
• Cencora Inc BCG Analysis
• Cencora Inc Segmentation, Targeting and Positioning (STP) Analysis
• Cencora Inc Ansoff Matrix Analysis

ページTOPに戻る

Table of Contents

Table of Contents 2
Tables 6
Charts 7
Cencora Inc - Key Company Facts 8
Cencora Inc - Company Description 9
Cencora Inc - Top Executives 10
Cencora Inc - Head Office & Locations 11
Head Office - Country 11
Cencora Inc - Products and Services 12
Products 12
Services 13
Cencora Inc - Corporate Strategy 15
Cencora Inc - Business Description 18
U S Healthcare Solutions Segment 18
International Healthcare Solutions Segment 19
Cencora Inc - ESG Spotlight 20
Environment 20
Social 21
Corporate Governance 22
Cencora Inc - SWOT Analysis 23
Overview 23
Strengths 25
Weaknesses 28
Opportunities 30
Threats 34
Cencora Inc - Financial Deep Dive 37
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 37
Profit and Loss Statement 39
Summary of Profit and Loss Statement 39
Balance Sheet 43
Summary of Balance Sheet 43
Cash Flow Statement 47
Summary of Cash Flow Statement 47
Key Financial Ratio Analysis 51
Cencora Inc - Ratio Charts 53
Activity Ratio Charts 53
Growth Ratios Charts 54
Leverage Ratio Charts 58
Liquidity Ratio Charts 60
Profitability Ratio Charts 62
Competing Players 64
Snapshot of Competing Players 65
Henry Schein Inc 65
Key Company Facts 65
Company Description 65
Key Financials 66
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 66
Key Financial Ratio Analysis 71
McKesson Corporation 73
Key Company Facts 73
Company Description 73
McKesson Corporation - SWOT Spotlight 74
McKesson Corporation - PESTLE Spotlight 76
Key Financials 78
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 78
Key Financial Ratio Analysis 83
Accendra Health, Inc 85
Key Company Facts 85
Company Description 85
Key Financials 86
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 86
Key Financial Ratio Analysis 91
Rite Aid Corporation 93
Key Company Facts 93
Company Description 93
Walgreens Boots Alliance, Inc 94
Key Company Facts 94
Company Description 94
Cencora Inc - In the News 95
27-May-2026 - Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer 95
06-May-2026 - Cencora leaders share insights at Asembia ASX26 99
24-Apr-2026 - Supply chain experts discuss FDA 12-digit NDC format 102
04-Mar-2026 - Matt Sample on DSCSA Developments 2026 104
15-Dec-2025 - Cencora accelerates OneOncology acquisition 106
15-Dec-2025 - Cencora Finalizes Agreement to Acquire TPG's Equity Interest in OneOncology 109
15-Dec-2025 - Morgan Lewis Advises Cencora on $7.4 Billion Acquisition of OneOncology 110
03-Dec-2025 - Enhancing global pharmaceutical logistics services 111
06-Nov-2025 - Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America 113
05-Nov-2025 - Cencora Announces $1 Billion Investment to Strengthen its U.S. Distribution Network 115
16-Oct-2025 - IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes 117
24-Sep-2025 - Cencora to Support Commercial Launch of Precigen's Novel Immunotherapy in the United States 119
27-Aug-2025 - Thoughtspot 2025 119
22-Aug-2025 - Heather Zenk - Supply Chain innovation 120
18-Aug-2025 - Media Statement on the Executive Order to Fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with Critical Drug Components 120
18-Jul-2025 - Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025 121
19-Jun-2025 - Alphega Pharmacy Invests in New Learning Management Platform 123
Cencora Inc - Key Deals 124
20-Mar-2024 - Cencora Partners with WeInfuse to Bolster Infusion Strategy 124
Appendix 126
Definitions 126
SWOT Analysis 126
PESTLE Analysis 126
Value Chain Analysis 126
ESG Spotlight 126
Financial Deep Dive 126
Financial Ratios 127
Activity Ratios 127
Growth Ratios 129
Leverage Ratios 132
Liquidity Ratios 134
Market Ratios 136
Profitability Ratios 138
Research Methodology 140
Disclaimer 141
Contact Us 141